Human Molecular Genetics Advance Access originally published online on January 2, 2007
Human Molecular Genetics 2007 16(2):223-232; doi:10.1093/hmg/ddl471
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
1 Institute for Cell Engineering, 2 Department of Neurology, 3 Department of Neuroscience, 4 Department of Physiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA and 5 National Neuroscience Institute, Singapore, Singapore
* To whom correspondence should be addressed at: 733 N. Broadway, Suite 731, Broadway Research Building, Baltimore, MD 21205, USA. Tel: +1 4106143359; Fax: +1 4106149568; Email: tdawson{at}jhmi.edu
Received November 13, 2006; Accepted December 14, 2006
Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) cause late-onset Parkinson's disease indistinguishable from idiopathic disease. The mechanisms whereby missense alterations in the LRRK2 gene initiate neurodegeneration remain unknown. Here, we demonstrate that seven of 10 suspected familial-linked mutations result in increased kinase activity. Functional and disease-associated mutations in conserved residues reveal the critical link between intrinsic guanosine triphosphatase (GTPase) activity and downstream kinase activity. LRRK2 kinase activity requires GTPase activity, whereas GTPase activity functions independently of kinase activity. Both LRRK2 kinase and GTPase activity are required for neurotoxicity and potentiate peroxide-induced cell death, although LRRK2 does not function as a canonical MAPkinasekinasekinase. These results suggest a link between LRRK2 kinase activity and pathogenic mechanisms relating to neurodegeneration, further supporting a gain-of-function role for LRRK2 mutations.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. A. Caldwell and K. A. Caldwell Traversing a wormhole to combat Parkinson's disease Dis. Model. Mech., July 1, 2008; 1(1): 32 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Greggio, I. Zambrano, A. Kaganovich, A. Beilina, J.-M. Taymans, V. Daniels, P. Lewis, S. Jain, J. Ding, A. Syed, et al. The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation J. Biol. Chem., June 13, 2008; 283(24): 16906 - 16914. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Weiss ROCO Kinase Activity Is Controlled by Internal GTPase Function Sci. Signal., June 10, 2008; 1(23): pe27 - pe27. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, C. Xie, E. Greggio, L. Parisiadou, H. Shim, L. Sun, J. Chandran, X. Lin, C. Lai, W.-J. Yang, et al. The Chaperone Activity of Heat Shock Protein 90 Is Critical for Maintaining the Stability of Leucine-Rich Repeat Kinase 2 J. Neurosci., March 26, 2008; 28(13): 3384 - 3391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deng, P. A. Lewis, E. Greggio, E. Sluch, A. Beilina, and M. R. Cookson Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase PNAS, February 5, 2008; 105(5): 1499 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Nichols, V. E. Elsaesser, N. Pankratz, M. W. Pauciulo, D. K. Marek, C. A. Halter, A. Rudolph, C. W. Shults, T. Foroud, and For the Parkinson Study Group PROGENI Investigato LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8 Neurology, October 30, 2007; 69(18): 1737 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Thomas and M. F. Beal Parkinson's disease Hum. Mol. Genet., October 15, 2007; 16(R2): R183 - R194. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Luzon-Toro, E. R. de la Torre, A. Delgado, J. Perez-Tur, and S. Hilfiker Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation Hum. Mol. Genet., September 1, 2007; 16(17): 2031 - 2039. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mandemakers, V. A. Morais, and B. De Strooper A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases J. Cell Sci., May 15, 2007; 120(10): 1707 - 1716. [Abstract] [Full Text] [PDF] |
||||







